Internal Medicine, Nephrology · Bayamon, PR
NPI
1760740849
Since 2012
Specialty
Internal Medicine, Nephrology
Code 207RN0300X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
Bayamon Medical Plaza Pr#2 Km11.7, Suite 403
Bayamon, PR, 00959
Phone (787) 602-1243
Medicare paid, 2024
$18K
150 services
Medicare patients, 2024
49
Average age 76
Drug cost, 2024
$2.7M
5,139 prescriptions
Company payments, 2025
$158K
From 25 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Eddie M Rodriguez-Castro was code 99213 (office e&m - established), 57 times for 30 patients. In total Eddie M Rodriguez-Castro billed 150 services in 8 codes, and Medicare paid $18K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-14.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 57 | 30 | $55.08 | $3,140 |
| 99203 Office E&M - New | Office | 11 | 11 | $78.57 | $864 |
By year: 2022 $25K for 208 services; 2023 $17K for 166 services; 2024 $18K for 150 services.
Medicare prescription drug claims, 2024
In 2024, the drug Eddie M Rodriguez-Castro prescribed most often to Medicare patients was Farxiga (Dapagliflozin Propanediol), with 903 prescriptions and refills. In total Eddie M Rodriguez-Castro wrote 5,139 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Farxiga Dapagliflozin Propanediol | 903 | 1,909 | 293 | $1.1M |
| Kerendia Finerenone | 354 | 432 | 74 | $285K |
| Jardiance Empagliflozin | 283 | 529 | 95 | $320K |
| Calcium Acetate Generic | 201 | 240 | 44 | $20K |
| Atorvastatin Calcium Generic | 165 | 455 | 69 | $2,600 |
| Ozempic Semaglutide | 160 | 166 | 31 | $160K |
| Losartan Potassium Generic | 155 | 455 | 79 | $2,367 |
| Rosuvastatin Calcium Generic | 135 | 373 | 49 | $2,639 |
| Sevelamer Carbonate Generic | 132 | 141 | 27 | $24K |
| Lisinopril Generic | 121 | 339 | 52 | $950 |
| Furosemide Generic | 119 | 277 | 54 | $898 |
| Tamsulosin Hcl Generic | 113 | 339 | 53 | $2,015 |
| Gabapentin Generic | 104 | 248 | 39 | $1,912 |
| Amlodipine Besylate Generic | 99 | 289 | 42 | $648 |
| Irbesartan Generic | 90 | 268 | 37 | $3,584 |
Brand drugs: 2,401 claims; generic drugs: 2,723 claims; opioid claims: 11.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Eddie M Rodriguez-Castro $158K ($158K in general payments such as food, travel and fees) from 25 companies. The largest payer was Amgen Inc. with $37K.
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. AMGN | 47 | $37K |
| GlaxoSmithKline, LLC. GSK | 24 | $33K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 29 | $30K |
| Travere Therapeutics, Inc. TVTX | 37 | $26K |
| ANI Pharmaceuticals, Inc. ANIP | 18 | $17K |
| Otsuka America Pharmaceutical, Inc. 4578.T | 11 | $9,507 |
| AstraZeneca Pharmaceuticals LP AZN | 15 | $2,122 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $503 |
| Vifor Pharma, Inc. | 9 | $333 |
| Lilly USA, LLC LLY | 5 | $285 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.